Clearmind Medicine, Inc. (CMND)
1.68
-0.06
(-3.45%)
USD |
NASDAQ |
Aug 24, 16:00
1.74
+0.06
(+3.57%)
After-Hours: 07:06
Clearmind Medicine Market Cap : 1.712M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.712M |
| August 21, 2026 | 1.773M |
| August 20, 2026 | 1.763M |
| August 19, 2026 | 1.946M |
| August 18, 2026 | 1.997M |
| August 17, 2026 | 1.926M |
| August 14, 2026 | 1.896M |
| August 13, 2026 | 1.885M |
| August 12, 2026 | 1.682M |
| August 11, 2026 | 1.641M |
| August 10, 2026 | 1.631M |
| August 07, 2026 | 1.661M |
| August 06, 2026 | 1.783M |
| August 05, 2026 | 1.794M |
| August 04, 2026 | 1.743M |
| August 03, 2026 | 1.661M |
| July 31, 2026 | 1.722M |
| July 30, 2026 | 1.651M |
| July 29, 2026 | 1.488M |
| July 28, 2026 | 1.488M |
| July 27, 2026 | 1.651M |
| July 24, 2026 | 1.641M |
| July 23, 2026 | 1.692M |
| July 22, 2026 | 1.702M |
| July 21, 2026 | 1.671M |
| Date | Value |
|---|---|
| July 20, 2026 | 1.906M |
| July 17, 2026 | 1.977M |
| July 16, 2026 | 2.028M |
| July 15, 2026 | 1.855M |
| July 14, 2026 | 1.967M |
| July 13, 2026 | 2.028M |
| July 10, 2026 | 2.069M |
| July 09, 2026 | 2.110M |
| July 08, 2026 | 2.140M |
| July 07, 2026 | 2.160M |
| July 06, 2026 | 2.385M |
| July 02, 2026 | 2.405M |
| July 01, 2026 | 2.344M |
| June 30, 2026 | 2.242M |
| June 29, 2026 | 2.344M |
| June 26, 2026 | 2.426M |
| June 25, 2026 | 2.538M |
| June 24, 2026 | 2.731M |
| June 23, 2026 | 3.027M |
| June 22, 2026 | 3.037M |
| June 18, 2026 | 3.129M |
| June 17, 2026 | 3.20M |
| June 16, 2026 | 3.20M |
| June 15, 2026 | 3.434M |
| June 12, 2026 | 3.404M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 4.739M |
| NervGen Pharma Corp. | 212.83M |
| Milestone Pharmaceuticals, Inc. | 129.48M |
| Lexaria Bioscience Corp. | 17.42M |
| Target Group, Inc. (Canada) | 0.6417M |
Market Cap Related Metrics
| PEG Ratio | -0.0024 |
| Price to Book Value | 0.149 |
| Price | 1.68 |
| Earnings Yield | -11.07K% |
| PEGY Ratio | -0.0024 |